Elevance (ELV) PT Lowered at Bernstein, Citing '2025 Pressures and Slower Recovery in Medicaid'
Tweet Send to a Friend
Bernstein SocGen Group analyst Lance Wilkes lowered the price target on Elevance (NYSE: ELV) to $445.00 (from $487.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
